High opioid doses inhibit whereas low doses enhance neuritogenesis in PC12 cells

Developmental Brain Research

Volumn 94, Issue 2, 1996, Pages 175-181

  Tenconi, Beatrice ^a   Lesma, Elena ^a   Digiulio, Anna Maria ^a   Gorio, Alfredo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Morphine; Nerve growth factor; Neuritogenesis; Opioid receptors; Regeneration

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALTREXONE; NALTRINDOLE; NERVE GROWTH FACTOR; OPIATE; SIGMA OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVE REGENERATION; NONHUMAN; PERINATAL DEVELOPMENT; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029764664     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(96)80009-5     Document Type: Article

References (36)

1. Calissano, P. and Shelanski, M.L., Interaction of NGF with pheochromocytoma cells. Evidence for tight binding and sequestration, Neuroscience, 5 (1980) 1033-1039.
2. Crain, S.M. and Shen, K.F., Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol. Sci., 11 (1990) 77-81.
3. 1 ganglioside, Brain Res., 575 (1992) 13-24.
4. Di Giulio, A.M., Tenconi, B., Malosio, M.L., Vergani, L., Bertelli, A. and Gorio, A., Exposure to perinatal morphine. I. Effects on synapsin I and neurotransmitter systems in the brain, J. Neurosci. Res., 42 (1995) 479-485.
5. Ferrari, G., Fabris, M. and Gorio, A., Gangliosides enhance neurite outgrowth in PC12 cells, Dev. Brain Res., 8 (1983) 215-221.
6. Germani, E., Lesma, E., De Biasi, S., Di Giulio, A.M., Bertelli, A. and Gorio, A., Exposure to perinatal morphine. II. Changes in cortical plasticity, J. Neurosci. Res., 42 (1995) 829-834.
7. Gorio, A., Tenconi, B., Zonta, N., Mantegazza, P. and Di Giulio, A.M., Reactive sprouting (pruning effect) is altered in the brain of rats perinatally exposed to morphine. In P.S. Timiras et al. (Eds.), Plasticity and Regeneration of the Nervous System, Plenum Press, New York, pp. 61-67.
8. Gorio, A., Di Giulio, A.M., Germani, E., Bendotti, C., Bertelli, A. and Mantegazza, P., Perinatal morphine treatment inhibit pruning effect and regeneration of serotoninergic pathways following neonatal 5,7-HT lesions, J. Neurosci. Res., 34 (1993) 462-471.
9. Greene, L.A. and Tischler, A.S., Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cell which respond to NGF, Proc. Natl. Acad. Sci. USA, 73 (1976) 2424-2428.
10. Greene, L.A. and Tischler, A.S., PC12 pheochromocytoma cultures in neurobiological research, Adv. Cell. Neurobiol., 3 (1982) 373-413.
11. Hauser, K.F., McLaughlin, P.J. and Zagon, I.S., Endogenous opioid systems and the regulation of dendritic growth and spine formation, J. Comp. Neurol., 281 (1989) 13-22.
12. Ilyinsky, O.B., Kozlova, M.V., Kondrikova, E.S., Kalentchuk, V.V., Titov, M.I. and Bespalova, Z.D., Effects of opioid peptides and naloxone on nervous tissue in culture, Neuroscience, 22 (1987) 719-735.
13. Isayama, T., McLaughlin, P.J. and Zagon, I.S., Endogenous opioids regulate cell proliferation in the retina of developing rat, Brain Res., 544 (1991) 79-85.
14. Martin, W.R., Pharmacology of opioids, J. Pharmacol. Rev., 35 (1984) 283-323.
15. McDowell, J. and Kitchen, I., Development of opioid systems: peptides, receptors and pharmacology, Brain Res. Rev., 12 (1987) 397-421.
16. McKnight, A.T. and Rees, D.C., Opioid receptor and their ligands. In RBI Neurotransmissions, Vol. VII, No. 2, 1991, pp. 1-6.
17. Meriney, S.D., Ford, M.J., Oliva, D. and Pilar, G., Endogenous opioids modulate neuronal survival in the developing avian ciliary ganglion, J. Neurosci., 11 (1991) 3705-3717.
18. Mudler, A.H., Burger, D.M., Wardeh, G., Hogenboom, F. and Frankhuyzen, A.L., Pharmacological profile of various κ-agonist and κ-, μ,- and δ-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain, Br. J. Pharmacol., 102 (1991) 518-522.
19. Paris, S. and Pouyssegur, J., Guanosine 5′-O-(3-thiotriphosphate) activates G proteins and potentiates fibroblast growth factor-induced DNA synthesis in hamster fibroblasts, J. Biol. Chem., 265 (1990) 11567-11575.
20. Portoghese, P.S., Lipkowski, A.W. and Takemori, A.E., Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists, Life Sci., 40 (1987) 1287-1292.
21. Portoghese, P.S., Sultana, M. and Takemori, A.E., Naltrindole, a highly selective and potent non-peptide opioid receptor antagonist, Eur. J. Pharmacol., 146 (1988) 185-186.
22. Shen, K.F. and Crain, S.M., Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors. Brain Res., 525 (1990) 225-231.
23. Shen, K.F. and Crain, S.M., Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid 'dependence' without tolerance. Brain Res., 597 (1992) 74-83.
24. Shen, K.F. and Crain, S.M., Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuates development of tolerance/dependence, Brain Res., 636 (1994) 286-291.
25. 1 ganglioside enhances the efficacy of opioid excitatory effects on the action potential, Brain Res., 559 (1991) 130-138.
26. Suarez-Roca, H., Abdulla, L., Zunica, Y., Madison, S. and Maixner, W., Multiphasic effect of morphine on the release of substance P from trigeminal nucleus slices, Brain Res., 579 (1992) 187-194.
27. Tao, P.L., Lee, C.R., Law, P.Y. and Loh, H.H., The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats, Naunyn-Schmiedeberg's Arch. Pharmacol., 348 (1993) 504-508.
28. Tenconi, B., Donadoni, M.L., Finco, C., Germani, E., Malosio, M.L., Di Giulio, A.M. and Gorio, A., Perinatal morphine exposure alters peptidergic development in the striatum, Int. J. Dev. Neurosci., 6 (1992) 517-526.
29. + currents, J. Neurosci. Res., 42 (1995) 493-503.
30. Zagon, I.S. and McLaughlin, P.J., Behavioural effects prenatal exposure to opiates, Monogr. Neural Sci., 9 (1983) 159-163.
31. Zagon, I.S. and McLaughlin, P.J., Naltrexone modulates tumor response in mice with neuroblastoma, Science, 221 (1983) 671-672.
32. Zagon, I.S. and McLaughlin, P.J., Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth, Life Sci., 35 (1984) 2057-2064.
33. Zagon, I.S. and McLaughlin, P.J., Opiates alter cell growth and differentiation in vitro, Natl. Inst. Drug Abuse Monogr., 49 (1984) 344-350.
34. Zagon, I.S. and McLaughlin, P.J., Endogenous opioid systems regulate cell proliferation in the developing rat brain. Brain Res., 412 (1987) 68-72.
35. Zagon, I.S. and McLaughlin, P.J., Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors, Brain Res., 480 (1989) 16-28.
36. Zukin, R.S., Sugarman, J.R., Fitz-Syage, M.L., Gardner, E.L., Zukin, S.R. and Gintzler, A.R., Naltrexone-induced opiate receptor supersensitivity, Brain Res., 245 (1982) 285-292.